Skip to main content
Sign In

Robert Booth, PhD         Robert E. Booth, PhD


Email:  Dr. Booth

Recent Publications


Robert E. Booth, PhD



Positions and Employment:

Instructor, University of Colorado, Boulder. Principal Evaluator, Problem-Drinking Felon Program, Southwest Denver Community Health Mental Health Center. Principal Evaluator, Hospital Improvement Project III, Fort Logan Mental Health Center, Denver, 1974 - 1976    

Director of Research and Evaluation, Southwest Denver Community Mental Health Center, Denver 1975 - 1977    

Director of Research and Evaluation, Colorado Division of Alcohol and Drug Abuse, Denver, 1976 - 1987    

Director of Institutional Research (80%) and Research Coordinator for Project Safe (20%), University of Colorado Health Sciences Center, Denver, Colorado, 1987 - 1990    

Assistant Professor (1990-1995); Associate Professor (1995-1999); Professor (2000-present) Department of Psychiatry, School of Medicine, University of Colorado Health Sciences Center, 1990 - present

Other Experience and Professional Memberships

Chair, Monitoring and Data Management Sub-Committee for the Cooperative Agreement, National Institute on Drug Abuse, 1990-1993.

Chair, Central Region Cooperative Agreement Grantees, Community Research Branch, National Institute on Drug Abuse, 1992 - 1995.

Member, Office of AIDS Research Advisory Council, 1999 – 2002.
Office of AIDS Research Advisory Council’s liaison to DAIDS/NIAID, 2000-2002.


  • Community Epidemiology Work Group, National Institute on Drug Abuse, 1978 -1987
  • American Public Health Association, 1992 – Present
  • College on Problems of Drug Dependence, 1994 – Present.
  • International Harm Reduction Association, 2004 – Present.
  • International AIDS Society, 2006 – Present.



Federal Research Fellow, University of Colorado, 1970 – 1972

Fellow, College on Problems of Drug Dependence, 2006

Award for Excellence in Global Health, University of Colorado Center for Global Health, 2010.

International Drug Abuse Research award for Excellence in Mentoring, National Institute on Drug Abuse, 2015.

Assistant Editor: Journal of Drug Issues, 1995 - present; AIDS and Behavior

Editorial Board Member: Journal of Substance Abuse Treatment


Grants and Contracts:

Recent/Ongoing Research Support

Life Course Investigation of People Who Inject Drugs
Grant  RO1 DA039072.  National Institute on Drug Abuse
2015 – 2020, $2,764,056
Role: Principal Investigator
Genetics and Progression of Early-onset Substance Dependence and HIV Risk
Grant R01 DA035804. National Institute on Drug Abuse
2014 – 2019
Role: Co-Investigator                                                          

The Impact of Medical Marijuana in Metropolitan Denver
Grant R01 DA031816.  National Institute on Drug Abuse
2011 - 2016, $2,665,460
Role: Principal Investigator

The Impact of Medical Marijuana in Metropolitan Denver
Grant R01 DA031816-04S1.  National Institute on Drug Abuse
2013 - 2015
Role: Principal Investigator

Peer Leaders as HIV Risk Reduction Change Agents among IDUs in Ukraine
Grant RO1 DA026739.  National Institute on Drug Abuse
2010 – 2014; $2,536,845
Role: Principal Investigator  

Reduction of drug use and HIV risk among out-of-treatment methamphetamine users
Grant R01 DA026741-02; National Institute on Drug Abuse
2010-2015; $2,889,276
Role: Co-Investigator

Structural Barriers to HIV Prevention and Treatment with IDUs in Ukraine
Grant R21 DA024590.  National Institute on Drug Abuse
2009 – 2011; $336,585
Role: Principal Investigator

Understanding the Role of Power in Drug Use and HIV Risk Behaviors among Non-Injecting Drug Users
Grant R21 DA024574.  National Institute on Drug Abuse
2009 – 2011; $344,472
Role: Principal Investigator

Intervention to Reduce Injection Drug Use
Grant RO1 DA09832.  National Institute on Drug Abuse
1995-2012; $7,373,382
Role: Principal Investigator


 Selected Peer-Reviewed Publications (since 2010, out of +150 publications)

Booth RE, Davis JM, Dvoryak S, Brewster JT, Lisovska O, Strathdee SA, Latkin CA.  HIV incidence among people who inject drugs (PWID) in Ukraine:  results from a clustered randomized trial.  The Lancet HIV. 2016;3:e482-9, PMID: 27658879 DOI: 10.1016/S2352-3018(16)30040-6   

Altice FL, Azbel L, Stone J, Brooks-Pollock E, Smyrnov P, Dvoryak S, Taxman FS, El-Bassel N, Martin NK, Booth RE, Stover H, Dolan K, Vickerman P.  The perfect storm:  incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.  The Lancet. 2016;388:1228-48, PMCID: PMC5087988 DOI: 10.1016/S0140-6736(16)30856-X

Booth RE, Davis JM, Brewster JT, Lisovska O, Dvoryak S.  Krokodile injectors in Ukraine:  Fueling the epidemic?  AIDS and Behavior.  Published online June 2, 2015.

Davis JM, Mendelson B, Berkes JJ, Suleta K, Corsi KF, Booth RE.  Public health effects of medical marijuana legalization in Colorado.  American Journal of Preventive Medicine.  Am J Prev Med. 2010;50:373-9 

Corsi KF, Dvoryak S, Garver-Apgar C, Davis JM, Brewster JT, Lisovska O, Booth RE.  Gender differences between predictors of HIV status among PWID in Ukraine.  Drug and Alcohol Dependence.  2014;138:103-108. 

Dvoryak S, Karachevsky A, Chhatre S, Booth RE, Metzger D, Schumacher J, Chychula N, Pecoraro A, Woody G.  Methadone maintenance for HIV positive and HIV negative patients in Kiev:  acceptability and treatment response.  Drug and Alcohol Dependence.  2014;137:62-67. 

Booth RE.  Krokodil and other home-produced drugs for injection:  A perspective from Ukraine.  International Journal of Drug Policy. 2013;24:277-278. 

Booth RE, Dvoryak S, Min S-J, Brewster JT, Wendt WW, Corsi KF, Semerik O, Strathdee SA.  Law enforcement practices associated with HIV infection among injection drug users in Odessa, Ukraine.   AIDS and Behavior.   Online: June 11 2013.

Thurstone C, Binswanger IA, Corsi KF, Rinehart DJ, Booth RE.  Medical Marijuana Use and Parenting: A Qualitative Study. Adolescent Psychiatry.  2013;3:190-194.

Corsi KF, Lehman WE, Sung-Moon M, Lance SP, Speer N, Booth RE, Shoptaw S.  The feasibility of interventions to reduce HIV risk and drug use among heterosexual methamphetamine users.  AIDS and Clinical Research.  ISSN:2155-6133 JAR open access journal; 2012.

Booth RE, Lehman WE, Latkin, CS, Dvoryak S, Brewster JT, Royer MS, Sinitsyna L.  Individual and network interventions with injection drug users in five Ukraine cities.  American Journal of Public Health.  2011;101:336-343. 

Booth RE, Campbell BK, Mikulich-Gilbertson SK, Tillotson C, Choi D, Robinson J, Calsyn D, Mandler R, Jenkins L, Thompson L, Dempsey C, Liepman M, McCarty D.  Reducing HIV-related risk behaviors among injection drug users in residential detoxification.  AIDS and Behavior.  2011;15:30-44.

Binswanger IA, Nowels C, Corsi KF, Long J, Booth RE, Kutner J, Steiner JF.  From the prison door to the sidewalk, everything went downhill,” A qualitative study of the health experiences of recently released inmates.  International Journal of Law and Psychiatry. 2011;34:249-255.

NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.  Tross S; Campbell AN; Calsyn DA; Metsch LR; Sorensen JL; Shoptaw S; Haynes L; Woody GE; Malow RM; Brown LS Jr; Feaster DJ; Booth RE; Mandler RN; Masson C; Holmes BW; Colfax G; Brooks AJ; Hien DA; Schackman BR; Korthuis PT; Miele GM; Clinical Trials Network HIV Special Interest Group.  American Journal of Drug & Alcohol Abuse. 37(5):283-93, 2011 Sep. [Journal Article. Research Support, N.I.H., Extramural. Research Support, Non-U.S. Gov't] UI: 21854270

Strathdee SA, Hallett TB, Bobrova N, Booth RE, Abdool R, Hankins CA.  HIV and risk environment for injecting drug users:  the past present, and future.  Lancet.  2010;379:268-284.. 

Binswanger IA, Merrill JO, Krueger PM, White MC, Booth RE, Elmore JG.  Gender differences in chronic medical, psychiatric, and substance-dependence disorders among jail inmates.  American Journal of Public Health.  2010;100:476-482. 

Nunes EV, Ball S, Booth RE, Brigham G.  et al.  Multisite effectiveness trials of treatments for substance abuse and co-occurring problems:  Have we chosen the best designs?  Journal of Substance Abuse Treatment.  2010:38 (Suppl 1):S97-S112.

Campbell BK, Tillotson CJ, Choi D, Bryant K, DiCenzo J, Provost SE, Zammarelli L, Booth RE, McCarty D.  Predicting outpatient treatment entry following detoxification for injection drug use:  the impact of patient and program factors.  Journal of Substance Abuse Treatment.  2010;38:S87-S96.  

Corsi KF, Rinehart DJ, Kwiatkowski CF, Booth RE.  Case management outcomes for women who use crack.  Journal of Evidence-Based Social Work.  2010;7:30-41.